San Diego Marriott Del Mar
San Diego, CA
Biotechnology companies are increasingly using single-asset spinouts as a way to create value, though the approach can be complex. This afternoon forum will examine considerations to strategically design and execute a successful spinout. Attendees will gain insight into the legal foundations of these transactions, including tax considerations, patent strategy, IP allocation, and structural design. The program will also explore the broader business drivers behind spinout decisions—such as capital formation, strategic focus, partnership alignment, governance, and long-term value creation.
Featuring perspectives from Wilson Sonsini attorneys alongside investors, pharmaceutical leaders, and seasoned biotech executives, the forum will provide practical guidance on how spinouts are evaluated and implemented in today's market. Participants will leave with a clearer understanding of common challenges, lessons learned, and the critical early-stage decisions that support sustainable success.
This event is by invite only. To request an invitation, contact Kaela Japson.
Presenters
